Dimethyl (2-oxo-4-phenylbutyl)phosphonate | CAS:41162-19-0

We serve Dimethyl (2-oxo-4-phenylbutyl)phosphonate CAS:41162-19-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Dimethyl (2-oxo-4-phenylbutyl)phosphonate

Chemical Name:Dimethyl (2-oxo-4-phenylbutyl)phosphonate
CAS.NO:41162-19-0
Synonyms:Dimethyl (2-oxo-4-phenylbutyl)phosphonate
1-dimethoxyphosphoryl-4-phenylbutan-2-one
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 362.7±25.0 °C at 760 mmHg
Melting Point 120-122 (0.5 MMHG)ºC
Molecular Formula C12H17O4P
Molecular Weight 256.235
Flash Point 186.8±43.5 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.494
 
Specification:
Appearance:Light yellow liquid
Assay:≥85.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bimatoprost(CAS:155206-00-1) and Latanoprost(CAS:130209-82-4).



Contact us for information like Dimethyl (2-oxo-4-phenylbutyl)phosphonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-dimethoxyphosphoryl-4-phenylbutan-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dimethyl (2-oxo-4-phenylbutyl)phosphonate Use and application,1-dimethoxyphosphoryl-4-phenylbutan-2-one technical grade,usp/ep/jp grade.


Related News: CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.1-iodo-4-methylbenzene manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.2-(4-hydroxyphenyl)-1-benzothiophen-6-ol vendor At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.